We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+2.36%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$26.2B
AUM Growth
+$914M
(+3.6%)
Cap. Flow
+$1.01B
Cap. Flow
% of AUM
3.87%
Top 10 Holdings %
Top 10 Hldgs %
32.55%
Holding
1,591
New
69
Increased
817
Reduced
431
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$107M |
| 2 |
EXL Service
EXLS
|
+$72M |
| 3 |
Apple
AAPL
|
+$64.3M |
| 4 |
Synopsys
SNPS
|
+$56.8M |
| 5 |
ServiceNow
NOW
|
+$54.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halozyme
HALO
|
+$74.5M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$53.5M |
| 3 |
Edwards Lifesciences
EW
|
+$45M |
| 4 |
Abbott
ABT
|
+$40.3M |
| 5 |
Rockwell Automation
ROK
|
+$39.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.4% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 12.04% |
| 4 | Communication Services | 9.47% |
| 5 | Industrials | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZUO
1451
DELISTED
Zuora, Inc.
ZUO
| $301K | ﹤0.01% |
30,300
+7,600
| +33% | +$73.7K |
|
|
KW
1452
DELISTED
Kennedy-Wilson Holdings
KW
| $297K | ﹤0.01% |
29,776
-300
| -1% | -$3.27K |
|
1453
Evolent Health
EVH
$471M
| $296K | ﹤0.01% |
26,300
+5,400
| +26% | +$94.9K |
|
1454
SiriusPoint
SPNT
$2.66B
| $296K | ﹤0.01% |
18,088
| – | – |
|
1455
Fiverr
FVRR
$311M
| $295K | ﹤0.01% |
9,300
| – | – |
|
1456
Employers Holdings
EIG
$864M
| $294K | ﹤0.01% |
5,737
| – | – |
|
1457
Coursera
COUR
$1.48B
| $292K | ﹤0.01% |
34,300
-10,300
| -23% | -$79.6K |
|
1458
Progyny
PGNY
$1.95B
| $292K | ﹤0.01% |
16,900
| – | – |
|
1459
Rocket Pharmaceuticals
RCKT
$374M
| $290K | ﹤0.01% |
23,100
+4,900
| +27% | +$73.8K |
|
1460
Westamerica Bancorp
WABC
$1.38B
| $290K | ﹤0.01% |
5,530
| – | – |
|
1461
Prothena Corp
PRTA
$475M
| $289K | ﹤0.01% |
20,900
+5,500
| +36% | +$86.8K |
|
1462
Garrett Motion
GTX
$5.47B
| $287K | ﹤0.01% |
31,800
+11,600
| +57% | +$96.3K |
|
1463
Virtus Investment Partners
VRTS
$1.12B
| $287K | ﹤0.01% |
1,300
+100
| +8% | +$22.8K |
|
1464
Tyson Foods
TSN
$19.6B
| $286K | ﹤0.01% |
4,975
+729
| +17% | +$44K |
|
1465
Sonic Automotive
SAH
$2.56B
| $285K | ﹤0.01% |
4,500
| – | – |
|
1466
Star Bulk Carriers
SBLK
$3.11B
| $285K | ﹤0.01% |
19,082
+3,616
| +23% | +$67.2K |
|
1467
Appian
APPN
$2.49B
| $284K | ﹤0.01% |
8,600
+1,100
| +15% | +$39.3K |
|
|
MFA
1468
MFA Financial
MFA
$925M
| $284K | ﹤0.01% |
27,847
| – | – |
|
1469
FB Financial Corp
FBK
$3.1B
| $283K | ﹤0.01% |
+5,500
| New | +$286K |
|
1470
Symbotic
SYM
$5.35B
| $282K | ﹤0.01% |
11,900
+2,600
| +28% | +$73.9K |
|
1471
Astrana Health
ASTH
$1.78B
| $281K | ﹤0.01% |
8,900
+400
| +5% | +$19K |
|
1472
United States Lime & Minerals
USLM
$3.42B
| $279K | ﹤0.01% |
+2,100
| New | +$266K |
|
1473
First Busey Corp
BUSE
$2.58B
| $276K | ﹤0.01% |
11,695
| – | – |
|
1474
Schrodinger
SDGR
$1.39B
| $276K | ﹤0.01% |
14,300
+2,300
| +19% | +$44.7K |
|
1475
S&T Bancorp
STBA
$1.82B
| $276K | ﹤0.01% |
7,216
| – | – |
|
Similar funds
VIA
Handelsbanken Fonder's Q4 2024 Portfolio in Review
As of Q4 2024, Handelsbanken Fonder held 1,591 positions worth $26.2B, up 3.6% from $25.3B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Handelsbanken Fonder deployed $1.01B of net new capital in Q4 2024, opening 69 new positions and adding to 817 existing holdings. Its largest new stake was GE Vernova: 105,537 shares worth $34.7M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Halozyme, an estimated $74.5M trimmed.
- Handelsbanken Fonder's largest Q4 2024 buy was GE Vernova: 105,537 shares worth $34.7M.
- Handelsbanken Fonder added most to Microsoft in Q4 2024, an estimated $107M increase.
- Handelsbanken Fonder's biggest Q4 2024 reduction was Halozyme, cutting an estimated $74.5M.
- Handelsbanken Fonder fully exited BeOne Medicines Ltd in Q4 2024, selling an estimated $5.92M.
- Handelsbanken Fonder's ten largest holdings make up 33% of its $26.2B portfolio in Q4 2024.
- Handelsbanken Fonder opened 69 new positions and closed 49 in Q4 2024.
- Handelsbanken Fonder's portfolio value rose 3.6% quarter-over-quarter to $26.2B.
Based on Handelsbanken Fonder's 13F filing for Q4 2024, filed 3 Feb 2025.